IceCure Medical Stock (NASDAQ:ICCM)
Previous Close
$0.80
52W Range
$0.53 - $1.66
50D Avg
$0.96
200D Avg
$1.09
Market Cap
$54.54M
Avg Vol (3M)
$1.73M
Beta
2.47
Div Yield
-
ICCM Company Profile
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.